Protectin DX, a double lipoxygenase product of DHA, inhibits both ros production in human neutrophils and cyclooxygenase activities

Lipids

Volumn 49, Issue 1, 2014, Pages 49-57

  Liu, Miao ^a   Boussetta, Tarek ^b   Makni Maalej, Karama ^b   Fay, Michèle ^b   Driss, Fathi ^b   El Benna, Jamel ^b   Lagarde, Michel ^a   Guichardant, Michel ^a  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Human neutrophils; Inflammation; NADPH oxidase; Protectin DX; ROS derived oxidative stress

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; LEUKOTRIENE B4; PROSTAGLANDIN SYNTHASE; PROTECTIN DX; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; NEUTROPHIL; THROMBOCYTE AGGREGATION INHIBITION;

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; ISOMERISM; LIPOPOLYSACCHARIDES; LIPOXYGENASE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NADPH OXIDASE; NEUTROPHILS; PEROXIDASE; PHOSPHORYLATION; PROSTAGLANDINS; REACTIVE OXYGEN SPECIES; SERINE; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 84891871011     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3863-6     Document Type: Article

References (47)

1. Mullenix PS, Andersen CA, Starnes BW (2005) Atherosclerosis as inflammation. Ann Vasc Surg 19:130-138 (Pubitemid 40568479)
2. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205 (Pubitemid 28307304)
3. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-429 (Pubitemid 34851835)
4. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436-444
5. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 107:499-511 (Pubitemid 36158056)
6. Esposito K, Giugliano D (2004) The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 14:228-232 (Pubitemid 39611863)
7. Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907-916 (Pubitemid 32224400)
8. Nathan C (2002) Points of control in inflammation. Nature 420:846-852 (Pubitemid 36019637)
9. Santana Reyes C, García-Muñoz F, Reyes D, González G, Dominguez C, Domenech E (2003) Role of cytokines (interleukin-1beta, 6, 8, tumour necrosis factor-alpha, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatr 92:221-227 (Pubitemid 36390428)
10. Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH (2012) Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21:822-835
11. Ortega-Gómez A, Perretti M, Soehnlein O (2013) Resolution of inflammation: an integrated view. EMBO Mol Med 5:661-674
12. Menshchikova E, Zenkov N, Tkachev V, Potapova O, Cherdantseva L, Shkurupiy V (2013) Oxidative stress and free-radical oxidation in BCG granulomatosis development. Oxid Med Cell Longev 2013:452546
13. Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukoc Biol 77:598-625 (Pubitemid 40628741)
14. Roos D, van Bruggen R, Meischl C (2003) Oxidative killing of microbes by neutrophils. Microbes Infect 5:1307-1315 (Pubitemid 37410244)
15. Babior BM (1984) Oxidants from phagocytes: agents of defense and destruction. Blood 64:959-966 (Pubitemid 15212033)
16. Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397:342-344 (Pubitemid 34852301)
17. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, Silliman CC (2005) Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol 78:1025-1042 (Pubitemid 41572466)
18. Whiting CV, Bland PW, Tarlton JF (2005) Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm Bowel Dis 11:340-349 (Pubitemid 40542265)
19. Serhan CN (2006) Resolvins and protectins: novel lipid mediators in anti-inflammation and resolution. Scand J Food Nutr 50:68-78 (Pubitemid 46018382)
20. Kohli P, Levy BD (2009) Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 158:960-971
21. Song HJ, Sneddon AA, Barker PA, Bestwick C, Choe SN, McClinton S, Grant I, Rotondo D, Heys SD, Wahle KW (2004) Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. Nutr Cancer 49:100-108 (Pubitemid 39299133)
22. Flowers M, Thompson PA (2009) t10c12 Conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBr 3 breast cancer cells: possible role of COX2. PLoS One 4:e5342. doi: 10.1371/journalpone0005342
23. Boussetta T, Raad H, Lettéron P, Gougerot-Pocidalo MA, Marie JC, Driss F, El-Benna J (2009) Punicic acid a conjugated linolenic acid inhibits TNFα-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One 4:e6458. doi: 10.1371/journalpone0006458
24. Chen P, Véricel E, Lagarde M, Guichardant M (2011) Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation. FASEB J 25:382-388
25. Chen P, Fenet B, Michaud S, Tomczyk N, Véricel E, Lagarde M, Guichardant M (2009) Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett 583:3478-3484
26. Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA (2006) Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 176:1848-1859 (Pubitemid 43134330)
27. Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y (2013) The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153:112-125
28. Dang PM, Stensballe A, Boussetta T, Raad H, Dewas C, Kroviarski Y, Hayem G, Jensen ON, Gougerot-Pocidalo MA, El-Benna J (2006) A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 116:2033-2043 (Pubitemid 44033327)
29. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
30. Watanabe T, Narumiya S, Shimizu T, Hayaishi O (1982) Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma. J Biol Chem 257:14847-14853 (Pubitemid 13159578)
31. Klebanoff SJ (1999) Myeloperoxidase. Proc Assoc Am Physicians 111:383-389 (Pubitemid 29446879)
32. Winterbourn CC, Kettle AJ (2000) Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic Biol Med 29:403-409
33. Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, Winyard PG, Kettle AJ (2012) Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology (Oxford) 51:1796-1803
34. Papadakis KA, Targan SR (2000) Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 119:1148-1157
35. Dewas C, Dang PM, Gougerot-Pocidalo MA, El-Benna J (2003) TNF-alpha induces phosphorylation of p47 (phox) in human neutrophils: partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-alpha and granulocyte-macrophage colony-stimulating factor. J Immunol 171:4392-4398 (Pubitemid 37238718)
36. El-Benna J, Dang PM, Gougerot-Pocidalo MA (2008) Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 30:279-289
37. Larmonier CB, Midura-Kiela MT, Ramalingam R, Laubitz D, Janikashvili N, Larmonier N, Ghishan FK, Kiela PR (2011) Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis 17:503-515
38. Zock PL, Katan MB (1998) Linoleic acid intake and cancer risk: a review and meta-analysis. Am J Clin Nutr 68:142-153 (Pubitemid 28307666)
39. Hatanaka E, Levada-Pires AC, Pithon-Curi TC, Curi R (2006) Systematic study on ROS production induced by oleic, linoleic, and gamma-linolenic acids in human and rat neutrophils. Free Radic Biol Med 41:1124-113239 (Pubitemid 44339600)
40. Martins de Lima-Salgado T, Coccuzzo Sampaio S, Cury-Boaventura MF, Curi R (2011) Modulatory effect of fatty acids on fungicidal activity, respiratory burst and TNF-α and IL-6 production in J774 murine macrophages. Br J Nutr 105:1173-1179
41. Wanten GJ, Janssen FP, Naber AH (2002) Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length. Eur J Clin Invest 32:285-289 (Pubitemid 36216595)
42. Lewis RA, Austen KF, Soberman RJ (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323:645-655 (Pubitemid 20280195)
43. Sakai M, Kakutani S, Horikawa C, Tokuda H, Kawashima H, Shibata H, Okubo H, Sasaki S (2012) Arachidonic acid and cancer risk: a systematic review of observational studies. BMC Cancer 12:606
44. Harbige LS (2003) Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38:323-341 (Pubitemid 36724289)
45. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res 65:211-222
46. Hardy SJ, Robinson BS, Poulos A, Harvey DP, Ferrante A, Murray AW (1994) The neutrophil respiratory burst. Responses to fatty acids, N- formylmethionylleucylphenylalanine and phorbol ester suggest divergent signalling mechanisms. Eur J Biochem 198:801-806
47. Paschoal VA, Vinolo MA, Crisma AR, Magdalon J, Curi R (2013) Eicosapentaenoic (EPA) and docosahexaenoic (DHA) acid differentially modulate rat neutrophil function in vitro. Lipids 48:93-103